Back

Multivariate Analysis Of Histopathological And Immunohistochemical Prognostic Factors In Endometrial Carcinoma. A Retrospective Pilot Study Of An Italian Regional Referral Center

Paudice, M.; Scaglione, G.; Biatta, C. M.; Barra, F.; Riva, M.; Spina, B.; Gaggero, G.; Fulcheri, E.; Ferrero, S.; Vellone, V. G.; San Martino Hospital Gynecologic Diagnosis Managment Team (Gyn DMT),

2020-12-11 pathology
10.1101/2020.12.09.20245779 medRxiv
Show abstract

Backgroundto investigate endometrial carcinoma prognostic value of some histopathological and immunohistochemical factors, fairly easily accessible in every routinely pathology lab set. Methodswe considered patients affected by endometrial carcinoma with available clinical and radiological follow-up data after radical hysterectomy (S. Martino Polyclinic Hospital, Genoa, Italy, period 1/1/2013 - 1/7/2016). We analyzed the following histopathological items: histotype, stage (FIGO), type of infiltration (infiltrative/espansive), desmoplasia, intratumoral necrosis, tumor infiltrating lymphocytes and lymph vascular spaces invasion. Moreover, each case has been investigated with a panel of immunohistochemistry including estrogen receptor , progesteron receptor, Ki67, p53, {beta}-catenin, e-cadherin, bcl-2 and cyclin D1. Primary endpoints were disease free survival and overall survival. Resultsout of 99 cases eligible for our purpose, we found 69 low-grade endometrioid, 8 high-grade endometrioid and 22 other high-grade endometrial carcinomas. Disease free survival multivariate analysis showed a strong significant correlation between poor prognosis and advanced stage (p=0.0042). Advanced stage (p=0.0003) and presence of desmoplasia (p=0.04) resulted significantly correlated to a worse prognosis in overall survival multivariate analysis. In univariate model, the non-endometrioid histotype was significantly correlated with an unfavorable prognosis when compared to the endometriod type. Same for progesteron receptor low expression. Conclusionthe multivariate analysis confirmed the central prognostic role of stage in endometrial carcinoma. Moreover, other immunohistochemical markers in univariate analysis, have confirmed their easily reproducible usefulness, well integrating the recent TGCA molecular classification.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 6%
23.1%
2
Journal of Clinical Pathology
12 papers in training set
Top 0.1%
12.7%
3
Cancers
200 papers in training set
Top 0.6%
7.0%
4
Modern Pathology
21 papers in training set
Top 0.1%
4.1%
5
Scientific Reports
3102 papers in training set
Top 30%
4.1%
50% of probability mass above
6
Diagnostics
48 papers in training set
Top 0.4%
3.7%
7
Cureus
67 papers in training set
Top 1%
3.7%
8
British Journal of Cancer
42 papers in training set
Top 0.6%
2.4%
9
Gene
41 papers in training set
Top 0.5%
2.4%
10
Journal of Pathology Informatics
13 papers in training set
Top 0.2%
2.1%
11
Heliyon
146 papers in training set
Top 1.0%
2.1%
12
Frontiers in Oncology
95 papers in training set
Top 2%
1.8%
13
International Journal of Cancer
42 papers in training set
Top 0.5%
1.8%
14
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.3%
1.7%
15
Biochemistry and Biophysics Reports
28 papers in training set
Top 0.6%
1.5%
16
BMC Cancer
52 papers in training set
Top 1%
1.5%
17
BMC Pregnancy and Childbirth
20 papers in training set
Top 0.5%
1.4%
18
Cells
232 papers in training set
Top 4%
1.3%
19
Journal of Medical Virology
137 papers in training set
Top 3%
1.0%
20
Frontiers in Medicine
113 papers in training set
Top 5%
1.0%
21
JNCI Cancer Spectrum
10 papers in training set
Top 0.4%
1.0%
22
Bioscience Reports
25 papers in training set
Top 1%
0.8%
23
Microorganisms
101 papers in training set
Top 2%
0.8%
24
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
25
F1000Research
79 papers in training set
Top 4%
0.8%
26
Journal of Family Medicine and Primary Care
10 papers in training set
Top 0.7%
0.7%
27
The Journal of Pathology
22 papers in training set
Top 0.6%
0.7%
28
Journal of Clinical Medicine
91 papers in training set
Top 7%
0.7%
29
Molecular Oncology
50 papers in training set
Top 1%
0.7%
30
Animals
20 papers in training set
Top 1%
0.5%